Brief Report: Prognostic Value of Kaposi Sarcoma Herpes Virus–Associated Clinical Symptom Scores in HIV-Associated Kaposi Sarcoma
BACKGROUND: Kaposi sarcoma herpes virus (KSHV)-associated inflammatory cytokine syndrome (KICS) is defined by clinical, laboratory, and radiographic findings and KSHV viremia. Whether the presenting clinical symptoms of KICS have prognostic value in patients with HIV-associated Kaposi sarcoma (HIV-KS) initiating therapy is unknown. SETTING: Two prospective clinical trials were conducted among participants with mild-to-moderate (A5264/AMC067) and advanced (A5263/AMC066) HIV-KS in low-income and middle-income countries. All participants received antiretroviral therapy, and chemotherapy was given according to the randomly assigned treatment arm. METHODS: We developed a Kaposi sarcoma clinical symptom score (KSCS score), derived from the previously described KICS definition to determine whether the score could inform prognosis. The score ranging from 0 to 3 was based on increasing severity of clinical manifestations. We evaluated the impact of baseline KSCS score on progression-free and overall survival using Cox proportional hazard regression. RESULTS: Of 190 participants in A5264/AMC067 and 329 in A5263/AMC066, 150 (78.9%) and 239 (72.6%) had KSCS score ≥1 and 15 (7.9%) and 95 (28.9%) had KSCS score 3, respectively. Independent of the treatment arm, participants with KSCS score 3 had a higher risk of death (A5264/AMC067: adjusted hazard ratio (aHR) = 9.17; 95% CI: 3.60 to 23.41; A5263/AMC066: aHR = 2.99; 95% CI: 1.69 to 5.28) and shorter progression-free survival (A5264/AMC067: aHR = 2.36 95% CI: 1.26 to 4.43; A5263/AMC066: aHR = 2.31; 95% CI: 1.23 to 3.60) compared with those with KSCS score ≤2. CONCLUSIONS: KSCS score symptoms are common, especially in advanced HIV-KS. KSCS score 3 is associated with higher risk of progressive KS disease or death, despite treatment with antiretrovirals and chemotherapy. This population may benefit from improved diagnostic and management options.
Authors
- Aggrey Bukuru
- Mina C. Hosseinipour (ORCID: https://orcid.org/0000-0003-2174-313X)
- Evangeline Wawira Njiru (ORCID: https://orcid.org/0000-0002-0064-8777)
- Thomas Campbell (ORCID: https://orcid.org/0000-0002-2325-4674)
- Rosie Mngqbisa
- Scott V. Adams (ORCID: https://orcid.org/0000-0002-8411-8051)
- Deborah Langat (ORCID: https://orcid.org/0000-0003-0439-1099)
- Carlee Moser (ORCID: https://orcid.org/0000-0001-5601-9112)
- Henriette Burger (ORCID: https://orcid.org/0000-0002-3941-568X)
- Margaret Ziona Borok (ORCID: https://orcid.org/0000-0002-1234-0913)
- Wadzanai P. Samaneka (ORCID: https://orcid.org/0009-0005-6636-0396)
- Naftali Wisindi Busakhala (ORCID: https://orcid.org/0000-0002-1229-3475)
- John D. MacRae
- Thomas S. Uldrick (ORCID: https://orcid.org/0000-0001-6959-0924)
- Susan E. Krown (ORCID: https://orcid.org/0000-0003-3395-062X)
- Maganizo Chagomerana (ORCID: https://orcid.org/0000-0003-4231-4553)
- Brenda Hoagland (ORCID: https://orcid.org/0000-0001-8210-3748)
- Kelvin Roland Mubiru (ORCID: https://orcid.org/0000-0001-8647-2399)
- Triin Umbleja (ORCID: https://orcid.org/0000-0001-7161-7743)
- McNeil Ngongondo (ORCID: https://orcid.org/0000-0003-3959-3774)
- Noluthando Mwelase (ORCID: https://orcid.org/0000-0002-8189-6149)
- Mulinda Nyirenda (ORCID: https://orcid.org/0000-0003-2037-7449)
- Michael D. Hughes (ORCID: https://orcid.org/0000-0001-8562-2316)
- Minhee Kang
Institutions
- University of North Carolina at Chapel Hill (US)
- Memorial Sloan Kettering Cancer Center (US)
- Harvard University (US)
- Johns Hopkins University (US)
- Moi University (KE)
- University of Zimbabwe (ZW)
- University of the Witwatersrand (ZA)
- Stellenbosch University (ZA)
- Asociación Civil Impacta Salud y Educación (PE)
- Tygerberg Hospital (ZA)
- Kenya Medical Research Institute (KE)
- Fred Hutch Cancer Center (US)
- Hutchinson Centre Research Institute in Uganda (UG)
- King Edward VIII Hospital (ZA)
- Instituto Evandro Chagas (BR)
- Joint Clinical Research Centre (UG)
- Kamuzu University of Health Sciences (MW)
- Instituto Nacional de Infectologia Evandro Chagas (BR)
- University of Colorado Anschutz Medical Campus (US)
- Fundação Oswaldo Cruz (BR)
- University of Colorado Denver (US)
Publication Details
- Journal
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1097/qai.0000000000003942
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00